NasdaqGS:ASMBBiotechs
Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives
Assembly Biosciences (ASMB) just closed FY 2025 with Q4 revenue of US$42.5 million and basic EPS of US$1.30, alongside trailing twelve month revenue of US$72.3 million and a trailing EPS loss of US$0.55. Over recent quarters the company has seen revenue move from US$7.4 million and an EPS loss of US$1.58 in Q4 FY 2024 to US$42.5 million and EPS of US$1.30 in Q4 FY 2025, while trailing twelve month net income narrowed to a loss of US$6.1 million. This sets up a results season where investors...